Protein Alternatives

ProAlt is a biotechnological company focused on the development and commercialization of biomarker-based assays for cancer diagnosis and clinical management.

[Protein Alternatives @ProAlt2006]

🔬 La semana pasada, PROALT patrocinó en la @urjc el evento “Hacia la medicina de precisión en cáncer de colon”, con participación de Custodia García Jiménez, José Manuel González Sancho, Rocío Díaz Sánchez, Natalia Pendás Franco y nuestro CEO, Juan Ignacio Imbaud.
👉

[Protein Alternatives @ProAlt2006]

🚀 Protein Alternatives will be be presenting at #BioTrinity2025 in Science Track 1!
📅 April 2 | 🕝 14:30-16:00
🔬 Science Spotlight Thirteen – New Platforms & Technologies for Drug Discovery
See you in London! ✨
#DrugDiscovery #Biotech #Innovation #ProteinAlternatives

[Protein Alternatives @ProAlt2006]

Protein Alternatives joins DIVAVACEHD project to develop a vaccine against Epizootic Hemorrhagic Disease (EHD) in cattle
https://t.co/qbtxiE4HUM
#ProteinAlternatives #Vaccines #Veterinary #EHD

[Protein Alternatives @ProAlt2006]

Protein Alternatives Welcomes Dr Antoni Castells Garangou, MD, PhD, to our Scientific Advisory Board
https://t.co/UmTkjT0rva
#Welcome #Oncology #ProteinAlternatives

[Protein Alternatives @ProAlt2006]

Protein Alternatives Welcomes Dr Alfredo Carrato Mena, MD, PhD, to our Scientific Advisory Board
https://t.co/HiXkCTluqs
#Welcome #Oncology #ProteinAlternatives

[Protein Alternatives @ProAlt2006]

Protein Alternatives Welcomes Prof. Eric Van Cutsem, MD, PhD, to our Scientific Advisory Board
https://t.co/yVq8j1gMRV
#Welcome #Oncology #ProteinAlternatives

[Protein Alternatives @ProAlt2006]

Protein Alternatives welcomes back Hugo Cartagena in his new role as COO
https://t.co/KbucLYs7BI
#WelcomeBack #Biotechnology #ProteinAlternatives

[Protein Alternatives @ProAlt2006]

Proalt will attend #biospain21 , which will take place at Pamplona from September 29th to October 1st

https://t.co/fNZhMbFIz3

[Protein Alternatives @ProAlt2006]

ProAlt was selected by the European Innovation Council (@EUeic) to participate in the EIC Corporate Day with Merck (@merckgroup)

[Protein Alternatives @ProAlt2006]

Protein Alternatives announces the opening of new office in Boston https://t.co/9ivTF0E0BB

[Global Colon Cancer Association @GlobalCRC]

Patient-friendly presentations on a variety of topics related to #colorectalcancer are available from our virtual #Congress2020. Check out https://t.co/S7OnMp8MbV. Did we mention it's 100% free? Enjoy the presentations and reach out to us with any ?s on socials [email protected]

[Protein Alternatives @ProAlt2006]

A new study by @nature on the transmissibility of #SARSCOV2 states that 44% of #COVID19 infections occurred before the onset of symptoms
https://t.co/l3ab4bw0cx

[Instituto de Salud Carlos III (ISCIII) @SaludISCIII]

El proceso de validación de centros que colaboren en el diagnóstico con PCR continúa en el #ISCIII. Hay más laboratorios en fases avanzadas de capacitación que, tras garantizar requisitos de seguridad y recursos, podrían sumarse a corto plazo a los 13 centros ya validados. ⬇️

[Protein Alternatives @ProAlt2006]

According to public health researchers at Harvard University, the overall duration of SARS-CoV-2 epidemic could last into 2022, and we may need to maintain social distancing until 2022 and follow-up of infections until 2024. https://t.co/exWdYGWQAo

[Protein Alternatives @ProAlt2006]

Los expertos reclaman una colaboración a nivel global para desarrollar la vacuna contra el coronavirus SARS-Cov-2
https://t.co/ReH1yta2T9 vía @el_pais

[Pedro Duque @astro_duque]

Me he reunido con varias empresas biotecnológicas para abordar la producción de kits diagnósticos.

Tienen la experiencia en I+D para fabricarlos. Hemos conversado sobre cómo hacer más desarrollos, asegurar los suministros y cómo podría ayudar el Gobierno. https://t.co/gysF4ncl0C

[SEV Virología @sev_virologia]

La ficha 8 de #InfoSEV sobre el #SARSCoV2 expone el curso de la enfermedad #COVID19, con sus cuatro escenarios típicos.

Recordad: tanto los infectados asintomáticos como los que muestran síntomas leves o moderados (aprox, 80% del total) tb son contagiosos, durante 2-3 semanas!

[CaixaResearch @CaixaResearch]

📢Announcing a new #CaixaImpulse Express Call for projects that address the #COVID19 pandemic.

🔹For projects or technologies focused on preventing, diagnosing, treating or monitoring this illness
🔹Selected projects will receive a grant of up to €300K

https://t.co/oIvR8URB9w

[Infosalus @infosalus_com]

La inmunoterapia previa a la cirugía puede hacer que el cáncer de colon se reduzca sustanciamente o desparezca

https://t.co/D6E3EZ7H34

[Protein Alternatives @ProAlt2006]

Protein Alternatives testará anticuerpos monoclonales frente al motivo RGD como un nuevo enfoque para el tratamiento de la COVID-19

https://t.co/b4VnCTf4BA

#COVID19 #SARSCoV2 #coronavirus #Antibodies